Internal Med

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Francis, R.J., et al. - Conclusion: Semiquantitative 18F-FDG PET using the volume-based parameter of TGV is feasible in mesothelioma and may predict response to chemotherapy and patient survival after 1 cycle of treatment. Therefore, metabolic imaging has the potential to improve the care of patients receiving chemotherapy for mesothelioma by the early identification of responding patients. This technology may also be useful in the assessment of new systemic treatments for mesothelioma


Today in Hematology/Oncology...keeping you current

Risk of dying from prostate cancer in men randomized to screening
Cancer, 10/13/09

Update on oral lichen planus
Expert Review of Dermatology, 10/14/09

Oestrogen plus progestin and lung cancer in postmenopausal women (Womens Health Initiative trial): a post-hoc analysis of a randomised controlled trial
The Lancet, 10/12/09

Today in Radiology/Diagnostics...keeping you current

Allergic rhinitis with negative skin tests: Does it exist
Allergy and Asthma Proceedings, 10/13/09

Risk of dying from prostate cancer in men randomized to screening
Cancer, 10/13/09

Hemoglobin A1C and diabetes diagnosis: The Rancho Bernardo Study
Diabetes Care, 10/28/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address